Condition
Infant, Extremely Low Birth Weight
Total Trials
7
Recruiting
1
Active
1
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
50%
3 of 6 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed6
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06676904Not ApplicableRecruiting
Neonatal Platelet Transfusion Threshold Trial
NCT02696343Not ApplicableCompletedPrimary
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants
NCT01702805Not ApplicableCompleted
Transfusion of Prematures Trial
NCT05322980CompletedPrimary
Summary of Infants Weighing 500 Grams or Less
NCT01534481Phase 3Completed
Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants
NCT02515266Completed
Additional Protein Fortification in Extremely Low Birth Weight Infants
NCT01150071CompletedPrimary
Growth, Health and Development in Children Born Extremely Preterm
Showing all 7 trials